Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
401 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2020
402 Preoperative Duloxetine to improve acute pain and quality of recovery in patients undergoing modified radical mastectomy: A dose-ranging randomized controlled trial Department of Anesthesia, Intensive care and Pain management Dr. Diab Fuad Hetta 2020
403 Neutropenic enterocolitis in pediatric leukemia patients treated with intensive chemotherapy in Upper Egypt Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2020
404 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2020
405 Right and Left Colon Cancer: Clinico-Pathological Features and Treatment Results (South Egypt
Cancer Institute Experience) 		Department of Medical Oncology Matta Gerges Mounir Meshreky 2020
406 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
 		Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2020
407 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2020
408 Age and Tumor Location Predict Survival in Nonmetastatic Osteosarcoma in Upper Egypt Department of Radiotherapy and Nuclear medicine Dr. Osama mostafa Abdelbadee Abou elhassan 2020
409 Epidemiological Characteristics and Etiology of Budd-Chiari Syndrome in Upper Egypt Department of Radiology Dr. Lamiaa Mohammed Refaat khalaf 2020
410 Adipocytokine, leptin, and resistin in combination with quantitative visceral adiposity as predictors of colorectal neoplasm: A case-control study Department of Clinical Pathology Dr. Engy adel shafeek 2020